Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 6 Issue 5

Quorum Sensing Inhibitor: A New Therapeutic Strategy

Rajesh K Das*

Department of Pharmaceutical Sciences, India

*Corresponding Author: Rajesh K Das, Department of Pharmaceutical Sciences, India.

Received: May 28, 2021; Published: April 01 , 2022

Abstract

The increasing resistance of antibiotics from the last few decades, it is crucial to find new techniques against pathogenic bacteria. Quorum sensing (QS) is the alternative target to introduce a new strategy. Synthetic and natural QSIs play a crucial role to inhibit these QS signals. In this article, I highlight some examples of QS inhibitors like natural and synthetic based QS inhibitors. This article focuses on the inhibition of QS mechanisms with some of its applications.

Keywords: Quorum Sensing; Antibiotics; Autoinducing Peptides

References

Citation

Citation: Rajesh K Das. “Quorum Sensing Inhibitor: A New Therapeutic Strategy". Acta Scientific Pharmaceutical Sciences 6.5 (2022): 01-02.

Copyright

Copyright: © 2022 Rajesh K Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Last Date to Submit Articles
    Journal accepting all the types of Articles for upcoing issue by on/before July 30, 2025
  • Issue of Publication Certificate
    Publication Certificate will be issued to the author after Online publication of an Article
  • Best Article
    One Article will be selected as Best Article from all the Articles of the corresponding Issue, once the issue released, and honored with A Best Article Certificate

Contact US